Today, The Clinical Trials Transformation Initiative (CTTI), released recommendations and best practices for the use of Data Monitoring Committees (DMCs). Congratulations to Berry Consultants team members, Dr. Roger Lewis and Dr. Jason Connor, for participating and providing their expertise as part of the CTTI team releasing these new recommendations. For the full article, see CTTI's website here. For the full recommendation report, see direct link here.
Blog: Time Trends in Clinical Trials (related to 2023 ASA Biopharm panel)
Blog by: Kert Viele On Thursday, I will be moderating a panel session (PS3B, 9/28/2023, 4:15-5:30 p.m.) at the ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop